Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

Ventzislav Petkov, Wilhelm Mosgoeller, Rolf Ziesche et al. · Journal of Clinical Investigation · 2003 · 343 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

In Vitro Properties of a High Affinity Selective Antagonist of the VIP1 Receptor

Philippe Gourlet, Philippe De Neef, Johnny Cnudde et al. · Peptides · 1997 · 184 citations

Medicine, Pharmacology, Pharmacodynamics +8

Moderate Pulmonary Arterial Hypertension in Male Mice Lacking the Vasoactive Intestinal Peptide Gene

Sami I. Said, Sayyed A. Hamidi, Kathleen G. Dickman et al. · Circulation · 2007 · 179 citations · Full text

Life Sciences, Cardiology, Physiology +17

VPAC Receptors for VIP and PACAP

Marc Laburthe, Alain Couvineau, Jean‐Claude Marie · Receptors and Channels · 2002 · 167 citations

Medicine, Neurobiology, Pharmacology +17

VPAC Receptors for VIP and PACAP

Marc Laburthe, Alain Couvineau, Jean‐Claude Marie · Receptors and Channels · 2002 · 158 citations · Full text

Medicine, Neurobiology, Pharmacology +17